General Information of the Compound
| Compound ID |
CP0412199
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-2-amino-N-[[5-benzyl-2-(propanoylamino)phenyl]methyl]-3-(4-hydroxy-2,6-dimethylphenyl)propanamide;2,2,2-trifluoroacetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H34F3N3O5
|
||||||||||||||||||
| Molecular Weight |
573.612
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)C(F)(F)F.CCC(=O)Nc1ccc(Cc2ccccc2)cc1CNC(=O)[C@@H](N)Cc1c(C)cc(O)cc1C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H33N3O3.C2HF3O2/c1-4-27(33)31-26-11-10-21(14-20-8-6-5-7-9-20)15-22(26)17-30-28(34)25(29)16-24-18(2)12-23(32)13-19(24)3;3-2(4,5)1(6)7/h5-13,15,25,32H,4,14,16-17,29H2,1-3H3,(H,30,34)(H,31,33);(H,6,7)/t25-;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VOEYLXRKOHJIJY-UQIIZPHYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01526, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01549, Mu-type opioid receptor